These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8362259)

  • 21. [The use of a concentrate of antithrombin III and disaggregants in the preoperative preparation of patients with pulmonary tuberculosis].
    Priĭmak AA; Makinskiĭ AI; Ivan'ko TP; Makarova VV
    Vrach Delo; 1990 May; (5):73-4. PubMed ID: 2396401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombin III concentrates.
    Menache D
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1115-20. PubMed ID: 1400075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antithrombin III].
    Mallofré F; Monasterio J; Monreal M
    Med Clin (Barc); 1989 Feb; 92(4):146-9. PubMed ID: 2469916
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of AT-III concentrate during liver transplantation.
    Christophe JL; Rouget C; Roullier M; Guyot F; Kieffer Y; Costes Y; Bresson S; Mantion G; Gillet M; Barale F
    Transplant Proc; 1991 Jun; 23(3):1942-3. PubMed ID: 2063435
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombin III in hematopoietic stem cell transplantation.
    Haire WD
    Semin Thromb Hemost; 1997; 23(6):591-601. PubMed ID: 9469635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial antithrombin III deficiency.
    Winter JH; Fenech A; Ridley W; Bennett B; Cumming AM; Mackie M; Douglas AS
    Q J Med; 1982; 51(204):373-95. PubMed ID: 7156320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low plasma levels of antithrombin III in the early post-operative period following pediatric liver transplantation: should they be replaced? A single-center pilot study.
    Quintero J; Ortega J; Miserachs M; Bueno J; Bilbao I; Charco R
    Pediatr Transplant; 2014 Mar; 18(2):185-9. PubMed ID: 24438318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early treatment with AT III in acute liver failure.
    Vogel GE
    Behring Inst Mitt; 1983 Aug; (73):79-93. PubMed ID: 6679286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin III concentrates--are they clinically useful?
    Lechner K; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient's disease and use of antithrombin III concentrates. S. Orsola Working Group on Liver Transplantation.
    Palareti G; Legnani C; Maccaferri M; Gozzetti G; Mazziotti A; Martinelli G; Zanello M; Sama C; Coccheri S
    Haemostasis; 1991; 21(2):68-76. PubMed ID: 1959800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].
    Kussmann J; Hirche H; Sengupta R
    Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Inhibition mechanism of blood coagulation--especially on the function of antithrombin III].
    Sakuragawa N
    Rinsho Byori; 1985 Sep; 33(9):974-81. PubMed ID: 3841167
    [No Abstract]   [Full Text] [Related]  

  • 37. Coagulation disorders after reperfusion of pancreatic allografts.
    Nader A; Büsing M; Blumenstock I; Heimburger N; Jochum M; Hopt UT
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1174-5. PubMed ID: 8442077
    [No Abstract]   [Full Text] [Related]  

  • 38. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome.
    Onyemelukwe GC; Jibril HB
    Trop Geogr Med; 1992 Jan; 44(1-2):37-41. PubMed ID: 1496720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.